Q&A: FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer’s Drug Approval
Similar Posts
3 Ways Communication is Improving Patient Outcomes in a Changing Industry
According to the 2019 Healthcare Trends Survey, caregiver empowerment and patient engagement are key to patient retention and practice…
EY Announces GreatCall CEO David Inns Named EY Entrepreneur Of The Year® 2016 Tech Services Award Winner in San Diego
2016 marks 30 years of ingenuity in America EY today announced that CEO David Inns of GreatCall Inc, the…
